Effort Designed to Safely and Efficiently Speed Drug Candidates into the Clinic Geneva, Switzerland – Selexis SA and Berkeley Lights, Inc. today announced a collaboration around the acquisition of Berkeley Lights’ Beacon® optofluidic platform. The partners will leverage the technology to accelerate cell line development (CLD) with the Selexis SUREtechnology Platform™. Selexis scientists have extensively evaluated the Beacon […]

Partnership will improve access to critical literature content and accelerate patient diagnosis OAKLAND, Calif. & ANN ARBOR, Mich.–Fabric Genomics™, a global leader in clinical interpretation of genomic data, and Genomenon®, the leading genomic data search company, announced today that they have entered into a partnership with the goal of further strengthening clinical genomic interpretation and variant […]

IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that Amgen (NASDAQ:AMGN) has announced an equity investment of £50 million into portfolio company Oxford Nanopore Technologies Limited (“Oxford Nanopore” or “the Company”).   The investment will be effected through the purchase of £50 million of existing ordinary […]

– Strategic Deal Extends and Diversifies Company’s Footprint in Life Science Research– Expands Luminex’s Flow-based Instrument Offering Into Cellular Analysis with Acquisition of Amnis and Guava Branded Instruments– Transaction Expected to Close by End of 2018 AUSTIN, Texas, Oct. 18, 2018 /PRNewswire/ — Luminex Corporation (NASDAQ: LMNX) today announced that the company has signed a definitive agreement to acquire […]

Merck today announced the signing of a definitive agreement to sell its Flow Cytometry unit to Luminex Corporation for €62.5 million. All associated reagents under these brands included in the deal Strategic agreement allows Luminex to increase footprint in multi-billion-dollar flow cytometry market Deal expected to close at end of 2018   Darmstadt, Germany, – Merck, the […]

Genomics England names Congenica as its Clinical Decision Support Service partner for the delivery of the NHS Genomic Medicine Service Cambridge, United Kingdom – Congenica has been awarded a multi-year contract by Genomics England, to be a provider of Diagnostic Decision Support Services for them to deliver for the world leading NHS Genomic Medicine Service. Genomics England […]

SAN DIEGO — Bionano Genomics, Inc. (NASDAQ: BNGO), a life sciences instrumentation company that develops and markets Saphyr, a platform for ultra-sensitive and ultra-specific structural variation detection in genome analysis, and Genoox, the healthcare technology company on a mission to make it easier for doctors, clinicians and researchers to run clinical genetic applications and act on […]

Agreement gives Teleflex access to Arcis’ nucleic acid sample preparation technology Daresbury, UK: Arcis Biotechnology (“Arcis”), the nucleic acid sample preparation solution provider, today announced it has signed a technology access agreement with Teleflex Incorporated, a New York Stock Exchange listed company (NYSE: TFX). Teleflex will harness Arcis’ advanced nucleic acid sample preparation chemistry in the […]

CE IVD Mark brings NGS-based clinical test for solid tumors to Europe CARLSBAD, Calif. — Marking a milestone in bringing its Oncomine Dx Target Test to Europe, Thermo Fisher Scientific today announced that it has CE-IVD marked its next-generation sequencing (NGS)-based solution that screens biomarkers across solid tumors. Thermo Fisher will highlight the test during the European Society for […]

Five new genomics startups focused on therapeutics, diagnostics and informatics Illumina Accelerator welcomes five new startups to its eighth investment cycle. The genomics-based company creation engine focuses on building early-stage genomics companies and helps startups validate and create next-generation sequencing applications and bring those products to market. During the six-month cycle, Illumina Accelerator offers the […]